ホーム › 前立腺がん › ニューヨーク › New York City
New York City、NYにおける前立腺がんの臨床試験
New York Cityとその周辺地域（約30マイル以内）の拠点で、前立腺がんに関する103件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
被験者募集中第1/2相
- Research Site, New York
- Research Site, New York
Developing New Educational Materials About Genetic Testing for a Diverse Group of Cancer Patients
被験者募集中
- Memorial Sloan Kettering at Ralph Lauren Center (Limited Protocol Activities), New York
A Study of Mental Health Care in People With Cancer
被験者募集中
- Memorial Sloan Kettering Cancer Center, New York
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
被験者募集中第1相
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- 他2件
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
被験者募集中第1/2相
- Columbia University Medical Center, New York
- Memorial Sloan Kettering, New York
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
被験者募集中第3相
- Mount Sinai Hospital, New York
- Memorial Sloan Kettering Cancer Center, New York
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
被験者募集中第3相
- Memorial Sloan Kettering Cancer Center, New York
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
被験者募集中第2相
- Mount Sinai Hospital, New York
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
被験者募集中観察研究健康なボランティア歓迎
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
被験者募集中第2相
- Memorial Sloan Kettering Hospital, New York
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
被験者募集中第2相
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- NYP/Weill Cornell Medical Center, New York
Precision-Based Genomics in Prostate Cancer
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
- Mount Sinai Hospital, New York
- Weill Cornell Medicine, New York
A Study of JNJ-87189401 Combined With JNJ-78278343 for Advanced Prostate Cancer
被験者募集中第1相
- Herbert Irving Comprehensive Cancer Center Columbia University Medical Center, New York
A Study of Pasritamig (JNJ-78278343) in Combination With JNJ-86974680 for Treatment of Prostate Cancer
被験者募集中第1相
- Columbia University Medical Center, New York
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
被験者募集中第1/2相
- Research Site, New York
A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer
被験者募集中第1相
- Columbia University Medical Center, New York
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
被験者募集中第3相
- Evelyn H. Lauder Breast and Imaging Center (BAIC)., New York
- Memorial Sloan Kettering Cancer Center - Main Campus, New York
- Sidney Kimmel Center for Prostate and Urological Cancers - Memorial Sloan Kettering Cancer Center, New York
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
被験者募集中第2/3相
- Mount Sinai Hosp Med School, New York
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
被験者募集中第1相
- New York University (NYU) Langone Medical Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
被験者募集中第3相
- Memorial Sloan Kettering Cancer Center, New York
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
被験者募集中第3相
- Weill Cornell Medicine NY-Presb, New York
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
被験者募集中第3相
- Research Site, New York
Comparing Two Different Boost Approaches in Radiation Therapy for People With Prostate Cancer
被験者募集中第3相
- Weill Cornell Medical Center (Data Collection Only), New York
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
被験者募集中第2相
- Manhattan Campus of the VA NY Harbor Healthcare System, New York, NY, New York
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
被験者募集中第3相
- Icahn School of Medicine at Mount Sinai ( Site 0009), New York
A Study of Changes to Prostate Procedures
被験者募集中第3相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
PROMISE Registry: A Prostate Cancer Registry of Outcomes and Germline Mutations for Improved Survival and Treatment Effectiveness
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
MDRT in Prostate Cancer Treated With Long-term Androgen Deprivation Therapy in the STAMPEDE Trial (METANOVA)
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
The SUGAR Study; SBRT and Relugolix) for Prostate Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
被験者募集中
- Integrated Medical Professionals, New York
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
被験者募集中第3相
- Mount Sinai Doctors Urology Faculty Practice, New York
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate or Salivary Gland Cancer
被験者募集中
- Memorial Sloan Kettering Cancer Center, New York
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
被験者募集中第3相
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
Short Course ADT for High Risk Low/Intermediate Risk ARTERA Prostate Cancer
被験者募集中第2相
- NYU Langone Health, New York
A Study of Tarlatamab for People With Prostate Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Phase Ib/II Platform Study of Multiple Anti-Cancer Agents in Participants With Metastatic Prostate Cancer
被験者募集中第1/2相
- Research Site, New York
PRISM Study: Prostate Recurrence Detection Using Imaging With PSMA PET/MRI Post-high Intensity Focused Ultrasound
被験者募集中観察研究
- NYU Langone Health, New York
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
被験者募集中第1相
- New York Cancer & Blood Specialists, New York
AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)
被験者募集中第3相
- Research Site, New York
Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
A Study of Talazoparib With or Without Enzalutamide in People With Prostate Cancer Who Have Previously Received Abiraterone Acetate or Darolutamide
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center, New York
A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC
被験者募集中第1/2相
- Memorial Sloan-Kettering Cancer Center (Mskcc), New York
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
被験者募集中第3相
- Mount Sinai Union Square, New York
- Mount Sinai Chelsea, New York
- Mount Sinai West, New York
- 他4件
FOG-001 in Locally Advanced or Metastatic Solid Tumors
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)
被験者募集中第1相
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Radiation Therapy Approaches for People With Prostate Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
Prospective Database of Clinical Outcomes Following Cryotherapy for Ablation of Clinically Localized Prostate Cancer
被験者募集中観察研究
- NYU Langone Health, New York
A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
被験者募集中
- Memorial Sloan Kettering Cancer Center, New York
MATCH-UP: MAking Telehealth-Delivery of Cancer Care at Home Effective and Safe-Upscaled: A Pragmatic Cluster Randomized Trial
被験者募集中
- Memorial Sloan Kettering Cancer Center (All Protocol Activites), New York
A Study on the Effects of Exercise Therapy on Signs of Prostate Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Clinical Outcomes in Prostate Cancer Patients Undergoing HIFU Ablation
被験者募集中観察研究
- NYU Langone Health - Tisch Hospital, New York
PSMA PET Combined With MRI for the Detection of PCa
被験者募集中第3相健康なボランティア歓迎
- Weill Cornell, New York
Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
被験者募集中第1相
- Investigative Site #103, New York
- Investigative Site #106, New York
PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
被験者募集中第3相
- Memorial Sloan Kettering Cancer Center, New York
The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)
被験者募集中第3相
- Columbia University Herbert Irving Comphrensive Cancer Center, New York
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
被験者募集中第1相
- Memorial Sloane Kettering Cancer Center, New York
A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)
被験者募集中第1相
- NYU Langone Health, New York
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
Improving Cryoablation Efficacy With BARRigel Rectal Spacing (ICE-BARR)
被験者募集中
- NYU Langone Health, New York
A Study of a New PET Scanner in People With Cancer
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
A Study of Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer
被験者募集中第1/2相
- Columbia University, New York
- Memorial Sloan Kettering Cancer Center, New York
A Study of Lower Dose Radiation Therapy for People With Prostate Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Risk Prostate Cancer
被験者募集中第2相
- Icahn School of Medicine at Mount Sinai, New York
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
被験者募集中第2相
- VA New York Harbor Healthcare System, New York
Phase I Study of 225Ac-J591 Plus 177Lu-PSMA Small Molecule for Progressive Metastatic Castration Resistant Prostate Cancer
被験者募集中第1相
- Weill Cornell Medicine New York Presbyterian, New York
The Use of Nanoparticles to Guide the Surgical Treatment of Prostate Cancer
被験者募集中第1相
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Tumor Microenvironment Analysis of Prostate Cancer Metastasis
被験者募集中観察研究
- Columbia University Irving Medical Center, New York
CUIMC Focal Therapy Registry
被験者募集中観察研究
- Columbia University Irving Medical Center, New York
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
被験者募集中観察研究
- Columbia University Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medical Center, New York
Brodalumab in the Treatment of Immune-Related Adverse Events
被験者募集中第1相
- Columbia University Irving Medical Center, New York
A Phase I Study of [225Ac]-AZD2284 in Patients With Metastatic Castration-Resistant Prostate Cancer
被験者募集中第1相
- Research Site, New York
Evaluation of Prostate Specific Membrane Antigen Positron Emission Tomography-Computed Tomography in Active Surveillance for Prostate CancEr
被験者募集中
- Weill Cornell Medicine - New York Presbyterian Hospital, New York
Photodynamic Therapy of Primary Localized Prostate Cancer With the SpectraCure P18 System
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
被験者募集中第1/2相
- Memorial Sloan Kettering Cancer Center, New York
Clinical Trial of Approaches to Prostate Cancer Surgery
被験者募集中
- Memorial Sloan Kettering Cancer Center, New York
- Weill Cornell Medicine, New York
Phase I/II Trial of Pembrolizumab and Androgen-receptor Inhibitor With or Without 225Ac-J591 for Progressive Metastatic Castration Resistant Prostate Cancer
被験者募集中第1/2相
- New York Presbyterian/Weill Cornell Medical Center, New York
- Columbia University Irving Cancer Center, New York
A Study of 2141-V11 in Combination With Standard Treatments in People With Prostate Cancer
被験者募集中第2相
- Memorial Sloan Kettering Cancer Center (All protocol activites), New York
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
被験者募集中第3相
- Manhattan Eye Ear and Throat Hospital, New York
- Lenox Hill Hospital, New York
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
被験者募集中
- The New York Proton Center, New York
Helping Men Adhere to Sexual Rehabilitation Following Prostate Cancer Surgery
被験者募集中
- Memorial Sloan Kettering Cancer Center, New York
A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies
被験者募集中第1/2相
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
Mechanisms of Resistance to PSMA Radioligand Therapy
被験者募集中観察研究
- Memorial Sloan Kettering, New York
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy
被験者募集中
- NYU Langone Health, New York
Diagnostic Utility of rhPSMA-7.3 (18F) PET/CT in Men With Prostate Cancer on Active Surveillance
被験者募集中第2相
- Mount Sinai Hospital / Icahn School of Medicine at Mount Sinai, New York
Study of AZD0754 in Participants With Metastatic Prostate Cancer
被験者募集中第1/2相
- Research Site, New York
- Research Site, New York
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
被験者募集中第1相
- NYU Langone Health, New York
- Memorial Sloan Kettering Cancer Center, New York
AVI Didactic Experience for Latinx Patient Treatment Adherence and Non-English Speaker Trial Enrollment Study in Rad Onc
被験者募集中
- Columbia University Irving Medical Center, New York
Two Fraction Prostate SBRT With DIL SIB
被験者募集中第1相
- NYCyberKnife at Perlmutter Cancer Center, New York
ADT and SBRT vs SBRT Alone for Unfavorable Intermediate Risk Prostate Cancer
被験者募集中第2相
- NYU Langone Health, New York
Study of PSMA PET/MR Guided Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost (SBRT-SIB) for High-Intermediate and High Risk Prostate Cancer
被験者募集中第2相
- Weill Cornell Medicine, New York
Upright MRI for Prostate Cancer Screening
被験者募集中観察研究
- Icahn School of Medicine at Mount Sinai, New York
Ablative Therapy in the Management of Prostate Cancer
被験者募集中観察研究
- Weill Cornell Medicine, New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
被験者募集中第1/2相
- Research Site 107, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
被験者募集中観察研究
- Massive Bio SYNERGY-AI site, New York
ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials
被験者募集中観察研究
- Memorial Sloan Kettering Cancer Center, New York
Feasibility of Timesaving When Using Histolog Confocal Laser Endomicroscopy for Margin Assessment in Prostatectomy Specimen
被験者募集中
- Icahn School of Medicine at Mount Sinai, New York
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
被験者募集中第3相
- NYP/Weill Cornell Medical Center, New York
Comprehensive Assessment of Cancer Theranostic Response
被験者募集中
- Weill Medical College of Cornell, New York
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
被験者募集中第1相
- Exelixis Clinical Site #5, New York
SAFE Nerve Sparing Guided by Micro-ultrasound (MUS)
被験者募集中第3相
- Mount Sinai Hospital, New York
Comprehensive Outcomes for After Cancer Health
被験者募集中健康なボランティア歓迎
- Memorial Sloan Kettering Cancer Center, New York
ART-Pro: Clinical Trial Evaluating Biparametric MRI and Advanced, Quantitative Diffusion MRI for Detection of Prostate Cancer
被験者募集中観察研究
- Weill Cornell Medical College, New York
Intratumoral and Systemic Hiltonol® (Poly-ICLC) in Prostate Cancer Patients on Active Surveillance
被験者募集中第2相
- Icahn School of Medicine at Mount Sinai (ISMMS), New York
他の都市における前立腺がんの試験
- Houston, TX76件の研究
- Los Angeles, CA61件の研究
- Boston, MA59件の研究
- St. Louis, MO46件の研究
- Chicago, IL45件の研究
- San Francisco, CA45件の研究
- Philadelphia, PA44件の研究
- Baltimore, MD43件の研究
- Nashville, TN43件の研究
- Seattle, WA42件の研究
- Washington, DC38件の研究
- Dallas, TX36件の研究
New York Cityにおける他の研究
- 乳がん136件の研究
- 非小細胞肺癌121件の研究
- がん（全種類）109件の研究
- 転移性癌93件の研究
- 大腸癌78件の研究
- 卵巣がん69件の研究
- 肺がん60件の研究
- 多発性骨髄腫60件の研究
- 膵臓がん60件の研究
- 子宮内膜がん52件の研究
- 急性骨髄性白血病51件の研究
- 心不全51件の研究
ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。